Market News AIOpen the app

SBFM stock news · Sunshine Biopharma

Stories about Sunshine Biopharma (SBFM) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for SBFM

Follow Sunshine Biopharma (SBFM) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for SBFM
Free on the App Store and Google Play, or on the web.
  1. Oct 15, 2026, 1:20 PM ET · Market

    On Thursday, 12 health care stocks saw big price changes, with Regencell Bioscience jumping up 30.4%.

    Neutral

    Sunshine Biopharma shares fell 15% in Thursday's session, but the article gives no company update. This trading report does not change the outlook for Sunshine Biopharma's business.

  2. Oct 13, 2026, 1:19 PM ET · Market

    12 health care stocks are changing a lot during Tuesday's trading.

    Neutral

    Sunshine Biopharma shares fell 23%, but the story gives no business update, so the move alone does not change its outlook.

  3. Oct 9, 2026, 1:13 PM ET · Market

    Here are 12 health care stocks that changed a lot during Friday's trading.

    Neutral

    Sunshine Biopharma shares fell 16% during Friday's session. The report gives no company news behind the move, so it does not change what we know about the business.

  4. Oct 8, 2026, 1:13 PM ET · Market

    On Thursday, 12 health care stocks saw big changes in their prices during the day.

    Neutral

    Sunshine Biopharma shares fell 44% during Thursday's session, but the article reports no company news. The share move alone does not change its business outlook.

  5. Oct 8, 2026, 8:16 AM ET · Market

    12 health care stocks are changing a lot before the market opens on Thursday.

    Neutral

    The roundup reports Sunshine Biopharma shares fell 16.02% before the market opened. It gives no company news to show a change in the business outlook.

  6. Oct 7, 2026, 1:13 PM ET · Market

    Here are 12 health care stocks that changed a lot during Wednesday's trading.

    Neutral

    Sunshine Biopharma shares rose about 151% to $1.00 per share. The story gives no company update, so this move alone does not change what we know about its business.

  7. Oct 6, 2026, 5:12 PM ET · Market

    12 health care stocks changed a lot in prices after the market closed on Tuesday.

    Neutral

    Sunshine Biopharma shares rose about 7% after hours, but the article gives no company news. The share-price move alone does not change the company's outlook.

  8. Oct 5, 2026, 1:09 PM ET · Market

    12 health care stocks are changing a lot during Monday's trading.

    Neutral

    Sunshine Biopharma shares fell 33.88% during Monday’s session, but the story gives no reason or company update. The price move alone does not change its business outlook.

  9. Oct 5, 2026, 1:08 PM ET · Market

    12 health care companies saw big changes during Monday's trading.

    Neutral

    Sunshine Biopharma's shares fell 34% on Monday. The story gives no company news to show that its business prospects changed.

  10. Oct 5, 2026, 9:50 AM ET · Market

    U.S. stocks had mixed results, with the Nasdaq up more than 50 points.

    Neutral

    Sunshine Biopharma shares fell 31%, but the story gives no company event or reason for the move. The share-price change alone does not show a change in the company's business prospects.

  11. Oct 5, 2026, 8:15 AM ET · Market

    12 health care companies are changing in price before the market opens on Monday.

    Neutral

    Sunshine Biopharma shares fell 20.5% before Monday's open, but the story gives no company news explaining the drop. It does not change the picture of Sunshine Biopharma's business.

  12. Oct 1, 2026, 5:18 PM ET · Market

    12 health care stocks changed a lot in prices after the market closed on Thursday.

    Neutral

    Sunshine Biopharma shares rose about 9% to $0.75 after hours, but the article reports no business update or reason for the move. It does not change the company's outlook.

  13. Sep 11, 2026, 6:50 PM ET · Market

    Sunshine Biopharma Inc. says it lowered the price for its Series B Warrants to $1.2046.

    Neutral

    Sunshine filed an 8-K saying Series B warrant exercise price fell to $1.2046 after ATM sales. I treat this as neutral for Sunshine.

  14. Aug 19, 2026, 8:40 AM ET · Market

    Canadian regulators grant approval to Sunshine Biopharma for its generic hypertension medication.

    Good for SBFM

    Sunshine Biopharma has received Canadian regulatory approval for its generic Enalapril tablets, marking a strategic entry into the hypertension market. This approval is expected to enhance the company's product portfolio and distribution capabilities in Canada, potentially leading to increased revenue from the growing antihypertensive drug sector.